Cms expands diabetes medicare coverage to include cgms that integrate with medtronic insulin pumps

Dublin, dec. 22, 2021 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, today announced that the u.s. centers for medicare & medicaid services (cms) will expand medicare coverage for all types of continuous glucose monitors (cgms), including adjunctive and non-adjunctive cgms. this includes cgms that integrate with medtronic insulin pumps.
MDT Ratings Summary
MDT Quant Ranking